Profiles for generic drugs starting with 'n'
✉ Email this page to a colleague
US Patents and Regulatory Information for n
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chase Labs Nj | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 072409-001 | Jul 4, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Unichem | NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 213830-004 | Mar 15, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Azurity | SULAR | nisoldipine | TABLET, EXTENDED RELEASE;ORAL | 020356-007 | Jan 2, 2008 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-003 | Apr 4, 2024 | RX | Yes | Yes | 11,957,662 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Technologies | NITROGLYCERIN | nitroglycerin | FILM, EXTENDED RELEASE;TRANSDERMAL | 074559-002 | Aug 30, 1996 | AB2 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-002 | Sep 29, 2023 | RX | Yes | Yes | 10,738,311 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
